Manoj Vyas (CEO – CBCC Global Research) will be attending The 42nd Annual J. P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 8 – 11 January 2024, at San Francisco, CA.

For more information on this conference, please visit: https://lnkd.in/eZBPTdbM

For business appointments please email us at: manoj.vyas@cbcc.global

We will be attending below upcoming events:

1. The 42nd Annual J. P. Morgan Healthcare Conference (8 – 11 January 2024, San Francisco, California)

2. Bio Asia 2024 (26 – 28 February 2024, Hyderabad, India)

3. Immuno-Oncology 360 (27 – 29 February 2024, New York)

4. DCAT Week (18 – 21 March 2024, New York)

We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster.

CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION

About CBCC Global Research

At CBCC Global Research, we are accelerating medical therapy development by providing high-quality, affordable and innovative solutions.

We provide strategic solutions for all phases of clinical trials through efficient delivery of services for the flawless execution of projects, on time – every time.

We are committed to achieving excellence in all research projects by ensuring scientific validity, data integrity, and compliance with the latest regulatory guidelines, thus striving to be a leading global clinical research organization (CRO).